✦ LIBER ✦

Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment

✍ Scribed by Laura A. Janzen; Brenda J. Spiegler

Publisher: Wiley (John Wiley & Sons)
Year: 2008
Tongue: English
Weight: 165 KB
Volume: 14
Category: Article
ISSN: 1940-5510
DOI: 10.1002/ddrr.24

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of life during active treatment

Quality of life during active treatment for pediatric acute lymphoblastic leukemia

✍ Lillian Sung; Rochelle Yanofsky; Robert J. Klaassen; David Dix; Sheila Pritchard 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract The objectives of the study were to describe quality of life (QoL), identify predictors of worse QoL and examine QoL during different phases of active therapy for acute lymphoblastic leukemia (ALL). A multiinstitutional cross‐sectional study was performed in children with ALL. We includ

Treatment of acute lymphoblastic leukemi

Treatment of acute lymphoblastic leukemia in adults

✍ Prof. Tiziano Barbui; Renato Bassan; Teodoro Chisesi; Raffaele Battista; Sergio 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie

Acute leukemia occurring 19 years after

Acute leukemia occurring 19 years after treatment of acute lymphoblastic leukemia

✍ Eduardo E. Reynoso; Armand Keating; Dr. Michael A. Baker 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

A 22-year-old woman presented with acute lymphoblastic leukemia (ALL) during pregnancy. She had been successfully treated for ALL at the age of 3 years and had received maintenance treatment for 11 years. Complete remission of 3 years or more is an important factor for long-term survival and potenti

Unexpected pancytopenia following treatm

Unexpected pancytopenia following treatment of acute lymphoblastic leukemia

✍ Andrew Innes; Philippa C. May; Jiří Pavlů; Barbara J. Bain 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

Incidence of secondary acute myelogenous

Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia

✍ Susan G. Kreissman; Richard D. Gelber; Harvey J. Cohen; Luis A. Clavell; Pearl L 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Neurodevelopmental outcome of infants wi

Neurodevelopmental outcome of infants with acute lymphoblastic leukemia : A Children's Cancer Group Report

✍ Thomas A. Kaleita; Gregory H. Reaman; William E. MacLean; Harland N. Sather; J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

The authors are thankful to a parent whose financial support provided much assistance in achieving the very high rate of follow-up neurodevelopmental evaluations. They also acknowledge the following individuals for their special efforts in locating children and helping to arrange a significant numbe